Obsidian, Galera Merger Comes With $350M Infusion for Cancer Drug TrialsNews DeskApril 19, 20260 Obsidian Therapeutics is merging with Galera Therapeutics to advance clinical development of a pipeline led by a next-generation cell therapy…